⌘K

Login Start Free

Home/Filings/4/0001516551-24-000101

4//SEC Filing

DHILLON PUNIT 4

Accession 0001516551-24-000101

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 8:31 PM ET

Size

5.6 KB

Accession

0001516551-24-000101

Insider Transaction Report

Form 4

Period: 2024-10-28

Skye Bioscience, Inc.SKYE

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
2024-10-28+650,000→ 650,000 total
Exercise: $5.15Exp: 2034-10-27→ Common Stock (650,000 underlying)

Footnotes (1)

[F1]The stock option vests in equal monthly installments over the four year period beginning October 28, 2024.

Documents

1 file

4
wk-form4_1730334676.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0001425052

Filing Metadata

Form type: 4
Filed: Oct 29, 8:00 PM ET
Accepted: Oct 30, 8:31 PM ET
Size: 5.6 KB

View on SEC.gov